gemcitabine has been researched along with Neoplasms, Pleural in 102 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (3.92) | 18.2507 |
| 2000's | 56 (54.90) | 29.6817 |
| 2010's | 37 (36.27) | 24.3611 |
| 2020's | 5 (4.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bonelli, C; Boni, L; Bonomi, M; Cappuzzo, F; Ceresoli, GL; de Marinis, F; Frega, S; Garassino, MC; Gervasi, E; Gianoncelli, L; Grossi, F; Grosso, F; Maconi, A; Pagano, M; Pasello, G; Pedrazzoli, P; Perrino, M; Pinto, C; Santoro, A; Soto Parra, H; Tiseo, M; Zanelli, F; Zucali, PA | 1 |
| Cordua, N; D'Antonio, F; De Vincenzo, F; Giordano, L; Perrino, M; Santoro, A; Zucali, PA | 1 |
| Assaraf, YG; Avan, A; Braczko, A; Cascioferro, S; Cloos, J; Deraco, M; Diana, P; El Hassouni, B; Funel, N; Giovannetti, E; Granchi, C; Jansen, G; Lagerweij, T; Li Petri, G; Mantini, G; Matherly, LH; Minutolo, F; Parrino, B; Peters, GJ; Sciarrillo, R; Smid, K; Smolenski, RT; Zaffaroni, N; Zeeuw van der Laan, EA; Zucali, PA | 1 |
| Nowak, AK | 1 |
| Bosch-Barrera, J; Cedrés, S; Coves, J; de Castro-Carpeño, J; García-Campelo, R; Guirado, M; López-Castro, R; Nadal, E; Ortega, AL; Vicente, D | 1 |
| De, A; Jacobson, BA; Jay-Dixon, J; Kratzke, MG; Kratzke, RA; Patel, MR; Peterson, MS; Sadiq, AA | 1 |
| Alhebshi, H; Bakker, E; Demonacos, C; Guazzelli, A; Hussain, M; Krstic-Demonacos, M; Meysami, P; Mutti, L; Schwartz, JM; Tian, K | 1 |
| Fahmy, ES; Habib, EE | 1 |
| Biffo, S; Burlando, B; Gallo, S; Martinotti, S; Mutti, L; Ranzato, E; Russo, MV; Volta, V | 1 |
| Abou-Elela, E; Darwish, D; Ibrahim, N | 1 |
| Akca, Z; Aksahin, A; Aslan, T; Berk, V; Buyukcelik, A; Erden, A; Karaca, H; Mutlu, H; Ozkan, M | 1 |
| Brahmbhatt, H; Cheng, YY; Edelman, JJ; Kirschner, MB; Klebe, S; MacDiarmid, JA; McCaughan, BC; Mugridge, N; Pel, ME; Reid, G; Vallely, MP; van Zandwijk, N; Weiss, J; Williams, M; Wright, C | 1 |
| Hirai, F; Ichinose, Y; Inamasu, E; Kojo, M; Morodomi, Y; Seto, T; Shimokawa, M; Shiraishi, Y; Takenaka, T; Takenoyama, M; Toyokawa, G; Toyozawa, R; Yamaguchi, M | 1 |
| Allo, G; Bitanihirwe, BK; de Perrot, M; Felley-Bosco, E; Friess, M; Frischknecht, L; Meerang, M; Moch, H; Opitz, I; Seifert, B; Soltermann, A; Stahel, R; Thies, S; Tsao, MS; Weder, W | 1 |
| Akamatsu, H; Endo, M; Imai, H; Kenmotsu, H; Murakami, H; Naito, T; Ono, A; Shukuya, T; Taira, T; Takahashi, T; Tokito, T; Yamamoto, N | 1 |
| Ginsberg, MS; Kass, SL; Krug, LM; Sima, CS; Woo, K; Zauderer, MG | 1 |
| Arslan, A; Baran, M; Cihan, YB; Deniz, K; Karaca, H; Ozturk, A | 1 |
| Aydin, S; Gizzi, M; Machiels, JP | 1 |
| de Lima, VA; Sørensen, JB | 1 |
| Ishii, J; Kaneko, H; Katagiri, T; Koda, T; Kubota, Y; Maeda, T; Otsuka, Y; Shibuya, K; Tamura, A; Tsuchiya, M | 1 |
| Frischknecht, L; Meerang, M; Moch, H; Opitz, I; Seifert, B; Soltermann, A; Stahel, R; Weder, W | 1 |
| Ak, G; Akarsu, M; Metintas, M; Metintas, S | 1 |
| Felley-Bosco, E; Friess, M; Frischknecht, L; Korol, D; Opitz, I; Soltermann, A; Stahel, R; Thies, S; Vrugt, B; Weder, W | 1 |
| Ceresoli, GL; Zucali, PA | 1 |
| Debus, J; Hoffmann, H; Huber, PE; Nicolay, NH; Roeder, F; Safi, S; Sterzing, F; Thieke, C | 1 |
| Akin, O; Arslan, A; Deniz, E; Ozcakir-Tomruk, C | 1 |
| Argiana, E; Froudarakis, ME; Karpathiou, G; Koutsopoulos, A | 1 |
| Nagai, S; Sonobe, M; Takenaka, K; Tanaka, F; Wada, H | 1 |
| Dowlati, A; Gadgeel, SM; Gill, J; Jänne, PA; Kalemkerian, GP; Kelly, K; Kindler, HL; Langer, CJ; Obasaju, CK; Peng, G; Simon, GR; Traynor, AM; Verschraegen, CF | 1 |
| Maniwa, Y; Nishimura, Y; Ohno, Y; Takata, M; Yoshimura, M | 1 |
| Anderson, H; Bishop, W; Lee, CW; Murray, N; Rao, SC | 1 |
| Anraku, M; Bezjak, A; Burkes, R; Cho, BC; de Perrot, M; Feld, R; Johnston, MR; Keshavjee, S; Leighl, N; Roberts, H; Tsao, MS | 1 |
| Takahashi, T; Tanaka, A | 1 |
| Abiko, M; Sato, T; Shiono, S; Tamura, G | 1 |
| Gkini, E; Gkiozos, I; Katirtzoglou, N; Kotteas, E; Makrilia, N; Ralli, M; Syrigos, K; Tourkantonis, I | 1 |
| Abe, K; Furuhashi, S; Maebayashi, T; Sakaguchi, M; Shizukuishi, T; Sugitani, M; Takahashi, M; Tanaka, Y; Uematsu, A | 1 |
| Alamara, C; Charpidou, A; Kotanidou, A; Makrilia, N; Nikolaidis, I; Ralli, M; Syrigos, K; Tourkantonis, I; Tsimpoukis, S | 1 |
| Betta, PG; Boidi, CD; Lingua, G; Monti, E; Orecchia, S; Osella, D; Zanellato, I | 1 |
| Kang, WK; Kim, ST; Lee, J; Lim, HY; Park, JO; Park, JY; Park, SH; Park, YS | 1 |
| Agatsuma, T; Fukushima, M; Hanaoka, M; Honda, T; Koizumi, T; Kubo, K; Tsushima, K; Urushihata, K; Yamamoto, H; Yasuo, M | 1 |
| Bueno, R; Mujoomdar, AA; Richards, WG; Sugarbaker, DJ; Tilleman, TR | 1 |
| Besse, B; Ferrand, FR; Le Floch, H; Mairovitz, A; Margery, J; Planchard, D; Rivière, F; Ruffié, P; Vaylet, F | 1 |
| Bonanno, L; Carli, P; Favaretto, A; Jirillo, A; Magro, C; Marulli, G; Nicotra, S; Pasello, G; Rea, F | 1 |
| Debeljak, A; Kovac, V; Marin, A; Rajer, M; Smrdel, U; Vrankar, M; Zwitter, M | 1 |
| Bernard, A; Chauffert, B; Facy, O; Ladoire, S; Magnin, G; Ortega-Deballon, P; Pages, PB; Royer, B | 1 |
| Albain, KS; Armato, SG; Brahmer, JR; Chen, HX; Gandara, DR; Jänne, PA; Karrison, TG; Kindler, HL; Koczywas, MN; Krug, LM; Lu, C; Quinn, DI; Stadler, WM; Stevenson, JP; Taber, DA; Vogelzang, NJ; Vokes, EE | 1 |
| Ishida, T; Tsubouchi, K; Yoshioka, H | 1 |
| Carboni, GL; Fahrner, R; Ochsenbein, A; Schmid, RA | 1 |
| Armato, SG; Dignam, JJ; Kindler, HL; Labby, ZE; Nowak, AK; Straus, C | 1 |
| Gurung, J; Lindemayr, S; Mbalisike, EC; Naguib, NN; Nour-Eldin, NE; Vogl, TJ; Zangos, S | 1 |
| Cameron, RB; Hou, D | 1 |
| Byrne, MJ; Fielding, D; Mitchell, P; Musk, AW; Nowak, AK; Robinson, BW; Ryan, G; Segal, A; Williamson, R | 1 |
| Hamano, R; Kawamata, O; Mori, M; Oota, T; Uda, M; Urakubo, N | 1 |
| Aversa, SM; Bortolotti, L; Favaretto, AG; Loreggian, L; Manzini, Vde P; Monfardini, S; Oniga, F; Paccagnella, A; Palmisano, V; Rea, F; Stefani, M | 1 |
| Nishiwaki, Y | 1 |
| Belyanskaya, L; Belyanskya, L; Cathomas, R; Hopkins-Donaldson, S; Kurtz, S; Simões-Wüst, AP; Stahel, RA; Zangemeister-Wittke, U | 1 |
| Hanibuchi, M; Hirano, H; Ito, M; Maeda, H; Nakagawa, M; Okumura, Y; Sawabata, Y; Takeda, S; Uematsu, K | 1 |
| Vogelzang, NJ | 1 |
| Cheong, K; Karapetis, CS; Li, J | 1 |
| Gadgeel, SM; Pass, HI | 1 |
| Edwards, JG; Martin-Ucar, A; O'Byrne, KJ; Pilling, JE; Stewart, DJ; Waller, DA | 1 |
| Ikehara, M; Noda, K; Oshita, F; Saitoh, H; Suzuki, R; Yamada, K | 1 |
| Byrne, MJ; Nowak, AK; Stockler, MR | 1 |
| Bodis, S; Jerman, M; Kestenholz, P; Lardinois, D; Stahel, RA; Taverna, C; Weder, W | 1 |
| Ishida, H; Miyake, M; Taki, T; Tomiyama, K | 1 |
| Alvarez, JM; Byrne, MJ; Millward, MJ; Nowak, AK; Robinson, BW | 1 |
| Büyükçelik, A; Utkan, G; Yalçin, B; Yalçin, S | 1 |
| Klabatsa, A; Steele, JP | 1 |
| Hobrack, E; Jehle, P; Nagel, S; Schütte, W | 1 |
| Botta, M; Bretti, S; Castagneto, B; Dongiovanni, D; Muzio, A; Numico, G; Sinaccio, G; Zai, S | 1 |
| Stahel, R; Weder, W | 1 |
| Flores, RM | 1 |
| Aoki, Y; Asoh, H; Ichinose, Y; Ikeda, J; Maruyama, R; Miyake, T; Miyamoto, T; Nakamura, T; Okamoto, T; Shoji, F; Wataya, H | 1 |
| Futagawa, T; Izumi, H; Miyamoto, H; Oh, T; Sonobe, S; Yamazaki, A | 1 |
| Akiyama, T; Hirata, K; Homma, H; Kogawa, K; Koike, K; Mezawa, S; Takahashi, S | 1 |
| Neragi-Miandoab, S | 1 |
| Kestenholz, P; Lardinois, D; Müller, M; Opitz, I; Rousson, V; Schneiter, D; Stahel, R; Weder, W | 1 |
| Bando, Y; Goto, H; Hamada, H; Kakiuchi, S; Kito, K; Matsumori, Y; Muguruma, H; Nakataki, E; Sone, S; Uehara, H; Yano, S; Yokoyama, A | 1 |
| Benedetti, G; De Pangher Manzini, V; Del Conte, G; dell'Amore, D; Galetta, D; Giaquinta, S; Lopez, M; Marino, A; Martoni, A; Mazzanti, P; Piana, E; Pinto, C | 1 |
| Bischoff, H; Giesel, FL; Kauczor, HU; Knopp, MV; von Tengg-Kobligk, H; Weber, MA; Zechmann, CM | 1 |
| Nakano, T | 1 |
| Becht, C; Culine, S; de Champfleur, NM; Pouessel, D; Vieillot, S | 1 |
| Barbone, D; Bertino, P; Busacca, S; Favoni, R; Gaudino, G; Germano, S; Mutti, L; Pinato, S; Porta, C; Tassi, G | 1 |
| Bortolotti, L; Breda, C; Favaretto, AG; Loreggian, L; Marulli, G; Rea, F; Sartori, F | 1 |
| Akhurst, T; Flores, RM; Heelan, R; Krug, LM; Rosenzweig, KE; Rusch, VW; Venkatraman, E; Vincent, A | 1 |
| Chella, A; Dini, P; Fontanini, G; Lucchi, M; Melfi, F; Mussi, A; Tibaldi, C | 1 |
| Ballabeni, P; Bernhard, J; Betticher, D; Bodis, S; Jermann, M; Lardinois, D; Mingrone, W; Ris, HB; Roth, AD; Schmid, R; Spiliopoulos, A; Stahel, RA; Stupp, R; Vogt, P; Weder, W | 1 |
| Chouaid, C; Fournel, P; Gimenez, C; Jullian, H; LeCaer, H; Letreut, J; Paillotin, D; Perol, M; Thomas, P; Vergnenegre, A | 1 |
| Adelstein, DJ; Borden, EC; Jacobs, AD; Kalmadi, SR; Keohan, ML; Kraut, MJ; Petrylak, DP; Rankin, C; Taub, RN | 1 |
| Adjei, AA; Aubry, MC; Delaune, R; Foster, NR; Kardinal, CG; Maurer, MJ; Nikcevich, DA; Northfelt, DW; Okuno, SH; Rowland, KM; Sloan, JA; Soori, GS | 1 |
| Campagnoli, E; Cappuzzo, F; Cavina, R; Ceresoli, GL; De Vincenzo, F; Garassino, I; Salamina, S; Santoro, A; Soto Parra, HJ; Zucali, PA | 1 |
| Dowlati, A; Fidias, P; Jänne, PA; Kindler, H; Langer, CJ; Monberg, M; Obasaju, C; Simon, GR; Taub, RN | 1 |
| Miller, V; Vander Els, NJ | 1 |
| Bamberg, M; Brandes, A; Classen, J; Schott, U; Weinmann, M | 1 |
| Ardizzoni, A; Baas, P; Debruyne, C; Giaccone, G; Gridelli, C; Groen, HJ; Lentz, M; Manegold, C; van Marck, EA; van Meerbeeck, JP | 1 |
| Buck, M; Byrne, MJ; Davidson, JA; de Klerk, NH; Dewar, J; Musk, AW; Robinson, BW; van Hazel, G | 1 |
| Atassi, G; Guilbaud, N; Jan, M; Kraus-Berthier, L; Naze, M; Pierré, A | 1 |
| Bagrova, SG | 1 |
| Baas, P; Burgers, JA; de Bruin, HG; de Jonge, MJ; Manegold, Ch; Mooi, WJ; Schouwink, JH; van Haarst, JM; van Klaveren, RJ; van Meerbeeck, JP | 1 |
| Riviere, A | 1 |
| Smythe, WR | 1 |
| Bunn, PA | 1 |
13 review(s) available for gemcitabine and Neoplasms, Pleural
| Article | Year |
|---|---|
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020).
Topics: Antineoplastic Agents; Asbestos; Carcinogens; Combined Modality Therapy; Cytoreduction Surgical Procedures; Deoxycytidine; Gemcitabine; Genetic Testing; High-Throughput Nucleotide Sequencing; Humans; Immunotherapy; Medical Oncology; Mesothelioma, Malignant; Neoplasm Staging; Pemetrexed; Platinum Compounds; Pleural Neoplasms; Radiotherapy; Societies, Medical; Spain; Vinorelbine | 2021 |
[A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Gemcitabine; Humans; Liver Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Oxonic Acid; Pancreatic Neoplasms; Pleural Neoplasms; Stomach Neoplasms; Tegafur | 2014 |
Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Pleural Neoplasms; Vinblastine; Vinca Alkaloids; Vinorelbine | 2015 |
[Malignant pleural mesothelioma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Pemetrexed; Pleural Neoplasms; Randomized Controlled Trials as Topic | 2003 |
Localized pleural malignant mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Male; Mesothelioma; Neoplasm Recurrence, Local; Paclitaxel; Pleural Neoplasms; Radiography, Thoracic; Tomography, X-Ray Computed | 2003 |
Novel combinations using pemetrexed in malignant mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Glutamates; Guanine; Humans; Mesothelioma; Organoplatinum Compounds; Pemetrexed; Pleural Neoplasms | 2004 |
Current chemotherapeutic treatment of malignant pleural mesothelioma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Therapy; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Mesothelioma; Pemetrexed; Pleural Neoplasms | 2004 |
Chemotherapy options and new advances in malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Gemcitabine; Glutamates; Guanine; Humans; Mesothelioma; Palliative Care; Pemetrexed; Pleural Neoplasms; Prognosis; Quinazolines; Randomized Controlled Trials as Topic; Thiophenes | 2005 |
Multimodality approach in management of malignant pleural mesothelioma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Genetic Therapy; Humans; Immunotherapy; Mesothelioma; Palliative Care; Pleural Neoplasms; Thoracic Surgical Procedures; Treatment Outcome | 2006 |
[Malignant mesothelioma--diagnosis and treatment strategies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asbestos; Camptothecin; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Interleukin-6; Irinotecan; Mediastinal Neoplasms; Mesothelioma; Pleural Neoplasms; Tomography, X-Ray Computed | 2006 |
[Does treatment for malignant pleural mesothelioma exist?].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Glutamates; Guanine; Humans; Immunotherapy; Interferons; Male; Mesothelioma; Middle Aged; Mitomycin; Multivariate Analysis; Paclitaxel; Palliative Care; Pemetrexed; Pleural Neoplasms; Pneumonectomy; Postoperative Care; Radiotherapy Dosage; Time Factors | 2001 |
Current therapy for malignant mesothelioma.
Topics: Antimetabolites, Antineoplastic; Asbestosis; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Mesothelioma; Pleural Neoplasms; Prognosis; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome | 2002 |
Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Folic Acid; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Pemetrexed; Pleural Neoplasms; Thymidylate Synthase; Vitamin B 12 | 2002 |
29 trial(s) available for gemcitabine and Neoplasms, Pleural
| Article | Year |
|---|---|
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Female; Gemcitabine; Humans; Italy; Male; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Progression-Free Survival; Ramucirumab; Time Factors | 2021 |
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Imatinib Mesylate; Male; Mesothelioma, Malignant; Pemetrexed; Pleural Neoplasms; Prognosis; Salvage Therapy; Survival Rate | 2020 |
Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Staging; Pemetrexed; Pleural Neoplasms; Prospective Studies; Survival Rate; Treatment Outcome | 2013 |
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Organoplatinum Compounds; Pemetrexed; Pleural Neoplasms; Survival Analysis | 2015 |
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Glutamates; Guanine; Humans; Kaplan-Meier Estimate; Male; Mesothelioma; Middle Aged; Pemetrexed; Pleural Neoplasms | 2008 |
Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Docetaxel; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Prognosis; Quality of Life; Survival Rate; Taxoids; Treatment Outcome | 2009 |
Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Deoxycytidine; Disease Progression; Docetaxel; Drug Therapy, Combination; Female; Follow-Up Studies; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome | 2011 |
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Quality of Life; Slovenia | 2012 |
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Deoxycytidine; Disease-Free Survival; Double-Blind Method; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Peritoneal Neoplasms; Placebos; Pleural Neoplasms | 2012 |
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Hematologic Diseases; Humans; Life Tables; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Quality of Life; Respiratory Function Tests; Survival Analysis; Treatment Outcome | 2002 |
Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Survival Rate | 2003 |
Phase II study of OK-432 intrapleural administration followed by systemic cisplatin and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Picibanil; Pleural Neoplasms; Survival Rate; Treatment Outcome | 2004 |
Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Pleural Neoplasms; Pneumonectomy; Survival Rate | 2004 |
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Neutropenia; Pleural Neoplasms; Survival Analysis; Thrombocytosis; Treatment Outcome | 2005 |
Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Female; Follow-Up Studies; Gemcitabine; Humans; Italy; Male; Mesothelioma; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Pleural Neoplasms; Retrospective Studies; Treatment Outcome | 2006 |
Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome.
Topics: Aged; Antimetabolites, Antineoplastic; Contrast Media; Deoxycytidine; Feasibility Studies; Female; Follow-Up Studies; Gadolinium DTPA; Gemcitabine; Humans; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Predictive Value of Tests; Treatment Outcome | 2006 |
Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.
Topics: Adult; Aged; Anemia; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Feasibility Studies; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Pleural Neoplasms; Pneumonectomy; Radiation Dosage; Radiotherapy, Adjuvant; Survival Analysis; Thrombocytopenia; Time Factors | 2007 |
Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prospective Studies | 2006 |
Four-modality therapy in malignant pleural mesothelioma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Epirubicin; Feasibility Studies; Female; Gemcitabine; Humans; Interleukin-2; Male; Mesothelioma; Middle Aged; Pleura; Pleural Neoplasms; Radiotherapy, Adjuvant | 2007 |
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Pleural Neoplasms; Pneumonectomy; Quality of Life; Radiotherapy | 2007 |
An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.
Topics: Age Factors; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Comorbidity; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Neoplasm Staging; Patient Selection; Pleural Neoplasms; Severity of Illness Index; Taxoids; Treatment Outcome | 2007 |
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms | 2008 |
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Injections, Intravenous; Leukopenia; Male; Mesothelioma; Middle Aged; Neutropenia; Pleural Neoplasms; Quality of Life; Remission Induction; Ribonucleotide Reductases; Survival Rate; Thrombocytopenia; Treatment Outcome | 2008 |
Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Pemetrexed; Pleural Neoplasms; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2008 |
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Pemetrexed; Pleural Neoplasms; Survival Analysis; Treatment Outcome | 2008 |
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Survival Analysis; Treatment Outcome | 1999 |
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Survival Rate; Tomography, X-Ray Computed | 1999 |
[Results of phase II clinical trial of cycloplatam in refractory solid tumors].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Organoplatinum Compounds; Pleural Neoplasms; Pleurisy; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine | 2001 |
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Survival Rate | 2002 |
60 other study(ies) available for gemcitabine and Neoplasms, Pleural
| Article | Year |
|---|---|
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds.
Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase IX; Cell Culture Techniques; Cell Hypoxia; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; L-Lactate Dehydrogenase; Mesothelioma, Malignant; Mice; Pemetrexed; Peritoneal Neoplasms; Pleural Neoplasms; Proton-Coupled Folate Transporter; Xenograft Model Antitumor Assays | 2020 |
New and old treatments for malignant mesothelioma: not just immunotherapy.
Topics: Deoxycytidine; Gemcitabine; Humans; Immunotherapy; Mesothelioma, Malignant; Pleural Neoplasms | 2021 |
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
Topics: Adaptor Proteins, Signal Transducing; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Deoxycytidine; Down-Regulation; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4F; Eukaryotic Initiation Factor-4G; Gemcitabine; Genome, Human; Humans; Hydrazones; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Phosphoproteins; Phosphorylation; Pleural Neoplasms; Polyribosomes; Protein Binding; Protein Biosynthesis; Proteome; Reproducibility of Results; RNA Caps; Thiazoles | 2018 |
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
Topics: Cell Line, Tumor; Cell Survival; Deoxycytidine; Etoposide; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Models, Biological; Neoplasm Staging; Pleural Neoplasms; Proportional Hazards Models; Transcriptome; Tumor Suppressor Protein p53; Wound Healing | 2018 |
Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Catechin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Inbred NOD; Mice, SCID; Pleural Neoplasms; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |
Survival of mesothelioma in a palliative medical care unit in egypt.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Egypt; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Morphine; Pain; Palliative Care; Pleural Neoplasms; Quality of Life; Retrospective Studies; Survival; Survival Rate; Vinblastine; Vinorelbine | 2013 |
Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Staging; Palliative Care; Pemetrexed; Platinum; Pleural Neoplasms; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2013 |
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.
Topics: Animals; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Nude; MicroRNAs; Neoplasm Transplantation; Pemetrexed; Pleural Neoplasms; RNA Interference; Transfection; Tumor Burden | 2013 |
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Staging; Pemetrexed; Pleural Neoplasms; Vinblastine; Vinorelbine | 2014 |
PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Cohort Studies; Combined Modality Therapy; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Induction Chemotherapy; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pemetrexed; Phosphatidylinositol 3-Kinase; Pleural Neoplasms; Pneumonectomy; Prognosis; PTEN Phosphohydrolase; Remission Induction; Signal Transduction; Survival Rate; Tissue Array Analysis; TOR Serine-Threonine Kinases | 2014 |
Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neutropenia; Pemetrexed; Pleural Neoplasms; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Young Adult | 2014 |
Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Retrospective Studies; Salvage Therapy; Vinblastine; Vinorelbine | 2014 |
ERCC1 as a biological marker guiding management in malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA-Binding Proteins; Endonucleases; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Pleural Neoplasms; Retrospective Studies; Treatment Outcome | 2014 |
Tubulocystic carcinoma of the kidney with fatal outcome in an adolescent male.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Renal Cell; Cisplatin; Deoxycytidine; Disease Progression; Fatal Outcome; Gemcitabine; Humans; Indoles; Kidney Neoplasms; Male; Nephrectomy; Pleural Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Time Factors; Treatment Outcome | 2015 |
Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Mesothelioma; Middle Aged; Neoplasms, Mesothelial; Pleural Neoplasms; Polyethylene Glycols; Retrospective Studies; Salvage Therapy | 2015 |
Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Deoxycytidine; Disease Progression; Disease-Free Survival; DNA-Binding Proteins; Endonucleases; Female; Gemcitabine; Glutamates; Guanine; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pemetrexed; Platinum Compounds; Pleural Neoplasms; Pneumonectomy; Predictive Value of Tests; Proportional Hazards Models; Ribonucleoside Diphosphate Reductase; Risk Factors; Time Factors; Tissue Array Analysis; Treatment Outcome; Tumor Suppressor Proteins | 2015 |
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cell Adhesion Molecules; Cell Line, Tumor; Chemotherapy, Adjuvant; Cohort Studies; Deoxycytidine; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Nestin; Pemetrexed; Platinum; Pleural Neoplasms; Pneumonectomy; Prognosis; Sarcoma; Stem Cell Factor | 2015 |
Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoadjuvant Therapy; Pemetrexed; Pleural Neoplasms; Pneumonectomy; Proportional Hazards Models; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Treatment Outcome | 2015 |
A case report of metastasis of malignant mesothelioma to the retromolar trigone.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Calbindin 2; Cisplatin; Deoxycytidine; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Mouth Neoplasms; Pemetrexed; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiography, Panoramic; Radiotherapy, Adjuvant | 2016 |
Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Palliative Care; Peritoneal Neoplasms; Pleural Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Schedule-dependent synergistic effect of pemetrexed combined with gemcitabine against malignant pleural mesothelioma and non-small cell lung cancer cell lines.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Pemetrexed; Peptide Synthases; Pleural Neoplasms; Reduced Folate Carrier Protein; RNA, Messenger; Thymidylate Synthase; Time Factors | 2008 |
Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fatal Outcome; Female; Gemcitabine; Humans; Mesothelioma; Middle Aged; Neoplasm Staging; Palliative Care; Patient Selection; Pleural Neoplasms; Tomography, X-Ray Computed; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2008 |
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Columbia; Cisplatin; Clinical Trials, Phase II as Topic; Cohort Studies; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Platinum; Pleural Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2009 |
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Pemetrexed; Pleural Neoplasms; Pneumonectomy; Quinazolines; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Thiophenes; Vinblastine; Vinorelbine | 2009 |
[Case of malignant pleural mesothelioma with long-term disease control after 4 different lines of systemic chemotherapy and pleurodesis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Drainage; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Pemetrexed; Pleural Neoplasms; Pleurodesis; Quality of Life; Time Factors; Vinblastine; Vinorelbine | 2009 |
Malignant solitary fibrous tumor with superior vena cava syndrome.
Topics: Adult; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Invasiveness; Pleural Neoplasms; Radiotherapy, Adjuvant; Solitary Fibrous Tumors; Sternum; Superior Vena Cava Syndrome; Tomography, X-Ray Computed; Treatment Outcome; Vascular Surgical Procedures | 2009 |
Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Humans; Hyperthermia, Induced; Ifosfamide; Neoplasm Proteins; Oncogene Proteins, Fusion; Pleural Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Synovial; Tomography, X-Ray Computed; Vincristine | 2010 |
In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Deoxycytidine; DNA Breaks, Double-Stranded; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Gemcitabine; Humans; Inhibitory Concentration 50; Mesothelioma; Pleural Neoplasms | 2011 |
The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Female; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Pemetrexed; Peritoneal Neoplasms; Pleural Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2010 |
Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Glutamates; Guanine; Humans; Mesothelioma; Pemetrexed; Pleural Neoplasms; Retroperitoneal Neoplasms; Salvage Therapy; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Vinblastine; Vinorelbine | 2010 |
Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Proliferation; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Feasibility Studies; Gemcitabine; Humans; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Patient Selection; Pleural Neoplasms; Time Factors; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2010 |
[Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Disease Progression; Feasibility Studies; Female; France; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Pemetrexed; Pleural Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome | 2010 |
Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Disease Progression; Drug Resistance; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Leukopenia; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pemetrexed; Platinum Compounds; Pleural Neoplasms; Thrombocytopenia | 2011 |
High-pressure intrapleural chemotherapy: feasibility in the pig model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Neoplasms; Pleural Neoplasms; Pressure; Swine; Tumor Cells, Cultured | 2012 |
Significant response to gemcitabine monotherapy in primary pleural epithelioid angiosarcoma.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Epithelioid Cells; Gemcitabine; Hemangiosarcoma; Humans; Male; Pleural Neoplasms; Prognosis; Tomography, X-Ray Computed | 2012 |
Long term survival after trimodal therapy in malignant pleural mesothelioma.
Topics: Adult; Aged; Chemoradiotherapy, Adjuvant; Deoxycytidine; Female; Gemcitabine; Glutamates; Guanine; Humans; Length of Stay; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pemetrexed; Platinum Compounds; Pleural Neoplasms; Pneumonectomy; Postoperative Complications; Retrospective Studies | 2012 |
Disease volumes as a marker for patient response in malignant pleural mesothelioma.
Topics: Aged; Aged, 80 and over; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Pleural Neoplasms; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Nonselective transarterial chemoperfusion: a palliative treatment for malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Infusions, Intra-Arterial; Male; Mesothelioma; Middle Aged; Mitomycin; Pain Measurement; Palliative Care; Pleural Neoplasms; Retrospective Studies; Statistics, Nonparametric; Surveys and Questionnaires; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; CHO Cells; Cisplatin; Combined Modality Therapy; Cricetinae; Cricetulus; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Glutamates; Guanine; Humans; Hyperthermia, Induced; Mesothelioma; Pemetrexed; Pleural Neoplasms; Time Factors; Tumor Stem Cell Assay | 2013 |
[Gemcitabine improved QOL and survival in a case of diffuse malignant pleural mesothelioma].
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Mesothelioma; Pleural Neoplasms; Prognosis; Quality of Life; Survivors | 2003 |
Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; bcl-X Protein; Blotting, Western; Caspases; Cell Division; Cisplatin; Combined Modality Therapy; Deoxycytidine; DNA Primers; Down-Regulation; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Potentials; Mesothelioma; Mitochondria; Oligonucleotides, Antisense; Pleural Neoplasms; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Ribonucleotide Reductases; Tumor Cells, Cultured | 2003 |
Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Drug Costs; Endpoint Determination; Gemcitabine; Humans; Mesothelioma; Organoplatinum Compounds; Oxaliplatin; Patient Care Planning; Pleural Neoplasms; Treatment Outcome | 2003 |
Gemcitabine and reactivation of hepatitis B.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Liver Function Tests; Pleural Neoplasms; Recurrence | 2003 |
The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Contraindications; Deoxycytidine; Diaphragm; Disease Progression; Female; Follow-Up Studies; Gemcitabine; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Pericardium; Pleural Neoplasms; Pneumonectomy; Prognosis; Prostheses and Implants; Radiotherapy, Adjuvant; Surgical Mesh; Survival Analysis; Thoracic Surgery, Video-Assisted; Treatment Outcome | 2004 |
Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Deoxycytidine; Endpoint Determination; Feasibility Studies; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Patient Compliance; Pleural Neoplasms; Predictive Value of Tests; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome | 2004 |
[Multimodality therapy for diffuse malignant pleural mesothelioma].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Male; Mesothelioma; Pleural Neoplasms; Pneumonectomy | 2004 |
Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: is it safe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Hemorrhage; Humans; Mesothelioma; Morbidity; Pleural Neoplasms; Pneumonectomy; Thromboembolism | 2005 |
[Second-line treatment of malignant pleural mesothelioma with Pemetrexed (Alimta) -- a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Forced Expiratory Volume; Gemcitabine; Glutamates; Guanine; Humans; Male; Mesothelioma; Organoplatinum Compounds; Pemetrexed; Pleural Neoplasms; Pyridines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Neoadjuvant chemotherapy in malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Mesothelioma; Neoadjuvant Therapy; Neoplasm Staging; Pleural Neoplasms | 2005 |
Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Glutamates; Guanine; Humans; Mesothelioma; Neoadjuvant Therapy; Neoplasm Staging; Pemetrexed; Pleural Neoplasms; Pneumonectomy; Radiotherapy, Adjuvant | 2005 |
Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Pneumonectomy; Survival Rate; Vinblastine; Vinorelbine | 2005 |
A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.
Topics: Aged; Biopsy, Needle; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Follow-Up Studies; Gemcitabine; Humans; Immunohistochemistry; Male; Mesothelioma; Neoplasm Invasiveness; Neoplasm Staging; Pleural Effusion, Malignant; Pleural Neoplasms; Risk Assessment; Thoracoscopy; Tomography, X-Ray Computed | 2005 |
[Intraperitoneal and intrapleural gemcitabine in patients with advanced pancreatic cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms; Pleural Cavity; Pleural Neoplasms | 2005 |
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Fistula; Gemcitabine; Glutamates; Guanine; Humans; Intraoperative Period; Length of Stay; Male; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pemetrexed; Pleural Diseases; Pleural Neoplasms; Pneumonectomy; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index | 2006 |
Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Deoxycytidine; Disease Models, Animal; Gemcitabine; Humans; Immunohistochemistry; Male; Mesothelioma; Mice; Mice, SCID; Neoplasm Transplantation; Pleural Neoplasms; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2006 |
Reversible posterior leukoencephalopathy syndrome after carboplatin therapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neurotoxicity Syndromes; Pleural Neoplasms | 2007 |
Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Death; Deoxycytidine; Gemcitabine; Genes, fms; Glutamates; Guanine; Humans; Imatinib Mesylate; Mesothelioma; Pemetrexed; Piperazines; Pleural Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Tumor Cells, Cultured | 2007 |
Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Glucocorticoids; Humans; Lung Neoplasms; Middle Aged; Pleural Neoplasms; Prednisolone; Ribonucleotide Reductases; Treatment Outcome | 1998 |
Impressive remission in a patient with locally advanced malignant pleural mesothelioma treated with gemcitabine.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Deoxycytidine; Dexamethasone; Fever; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Nausea; Pleural Neoplasms; Remission Induction; Tomography | 1999 |
Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Doxorubicin; Ellipticines; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Nude; Neoplasm Metastasis; Paclitaxel; Pleural Neoplasms; Topotecan; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2000 |